Publication Date:
1994-06-10
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Marshall, E -- New York, N.Y. -- Science. 1994 Jun 10;264(5165):1530.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/8202706" target="_blank"〉PubMed〈/a〉
Keywords:
Antiviral Agents/*adverse effects/therapeutic use
;
Arabinofuranosyluracil/adverse effects/*analogs & derivatives/therapeutic use
;
Clinical Trials as Topic/*standards
;
Drug-Induced Liver Injury
;
Federal Government
;
Government Regulation
;
Hepatitis B/*drug therapy
;
Humans
;
National Institutes of Health (U.S.)
;
Pancreatic Diseases/chemically induced
;
*Research Subjects
;
United States
;
United States Food and Drug Administration
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics